EXAS
EXACT Sciences Corporation
NASDAQ: EXAS · HEALTHCARE · DIAGNOSTICS & RESEARCH
$104.91
+0.00% today
Updated 2026-03-24
Market cap
$20.03B
P/E ratio
—
P/S ratio
6.17x
EPS (TTM)
$-1.10
Dividend yield
—
52W range
$39 – $1,878
Volume
2.7M
EXACT Sciences Corporation (EXAS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-8.5%
Last 4 quarters
Revenue YoY growth
+23.1%
Most recent quarter
EPS YoY growth
+12.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.4%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-8.9%
2025-08-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-13 | $-0.21 | -362.5% | $103.23 | $103.31 | +0.1% |
| 2025-11-03 | $0.24 | +50.0% | $64.69 | $69.59 | +7.6% |
| 2025-08-06 | $-0.01 | +92.3% | $47.36 | $43.16 | -8.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.08 | $-0.21 | -362.5% | $878.38M | +23.1% |
| 2025-09-30 | $0.16 | $0.24 | +50.0% | $850.74M | +20.0% |
| 2025-06-30 | $-0.13 | $-0.01 | +92.3% | $811.09M | +16.0% |
| 2025-03-31 | $-0.47 | $-0.36 | +23.8% | $706.78M | +10.9% |
| 2024-12-31 | $-0.33 | $-0.24 | +27.7% | $713.42M | +10.3% |
| 2024-09-30 | $-0.21 | $-0.21 | +0.0% | $708.65M | +12.8% |
| 2024-06-30 | $-0.24 | $-0.06 | +75.0% | $699.26M | +12.4% |
| 2024-03-31 | $-0.41 | $-0.54 | -31.7% | $637.52M | +5.8% |
| 2023-12-31 | $-0.36 | $-0.43 | -19.4% | $646.88M | — |
| 2023-09-30 | $-0.43 | $-0.32 | +25.6% | $628.34M | — |
| 2023-06-30 | $-0.41 | $-0.35 | +14.6% | $622.09M | — |
| 2023-03-31 | $-0.66 | $-0.35 | +47.0% | $602.45M | — |
Frequently asked questions
Has EXACT Sciences Corporation beaten earnings estimates?
EXACT Sciences Corporation has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -8.5% over the last 4 quarters.
How does EXAS stock react to earnings?
EXAS stock has moved an average of -0.4% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is EXACT Sciences Corporation's revenue growth rate?
EXACT Sciences Corporation reported year-over-year revenue growth of +23.1% in its most recent quarter, with EPS growing +12.6% year-over-year.